CIK 0000899923
- Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 870494517
- Phone
- +1 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- 4 Shares withheld for taxes Chief Commercial Officer gave up 3,523 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 4,402 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Technology Officer gave up 858 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 133 shares (to pay taxes)
- 4 Grant or award Chief Accounting Officer acquired 10,000 shares (grant or award)
- 4 Grant or award SVP, Chief of Staff acquired 10,000 shares (grant or award)
- 4 Shares withheld for taxes Chief Commercial Officer gave up 1,076 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 218 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 74,235 shares (to pay taxes)
- 4 Grant or award Director acquired 7,575 shares (grant or award)
- 4 Grant or award Director acquired 15,151 shares (grant or award)
- 4 Grant or award Director acquired 15,151 shares (grant or award)
- 4 Open-market sale Director sold 8,638 shares at $23.01 ($198,760)
- 4 Grant or award Director acquired 15,151 shares (grant or award)
- 4 Grant or award Director acquired 15,151 shares (grant or award)
- 4 Grant or award Director acquired 15,151 shares (grant or award)
- 4 Grant or award Director acquired 15,151 shares (grant or award)
- 4 Shares withheld for taxes Chief Commercial Officer gave up 703 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 638 shares (to pay taxes)
- 4 Open-market sale Chief Operating Officer sold 6,433 shares at $23.48 ($151,047)
Page 10 of 65 · 1,293 filings